Zobrazeno 1 - 10
of 199
pro vyhledávání: '"Peter V Dicpinigaitis"'
Autor:
Philip S. Yune, Iffath Islam, Peter V. Dicpinigaitis, Johanna P. Daily, Louis M. Weiss, Sun O. Park
Publikováno v:
Case Reports in Infectious Diseases, Vol 2022 (2022)
Babesiosis, a tick-borne protozoan disease, has been increasing in frequency in recent years. Familiarity with presentations of babesiosis is important for clinicians. Acute respiratory distress syndrome (ARDS) is a rarely seen complication of severe
Externí odkaz:
https://doaj.org/article/343272a9e8f745d6bfdd390fa3871d82
Autor:
Luke Andrea, MD, Peter V. Dicpinigaitis, MD, Melissa J. Fazzari, PhD, MS, Sumit Kapoor, MD, FCCP
Publikováno v:
Critical Care Explorations, Vol 3, Iss 8, p e0508 (2021)
OBJECTIVES:. Few studies have reported the complications and outcomes of patients with Legionella pneumonia requiring ICU admission. The objective of our study is to report the clinical course, complications, and 30-day mortality of patients with Leg
Externí odkaz:
https://doaj.org/article/73bfc57264d2498dbecfbdb152b38eed
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Symptoms associated with lung cancer mainly consist of cancer-associated pain, cough, fatigue, and dyspnea. However, underlying mechanisms of lung cancer symptom clusters remain unclear. There remains a paucity of effective treatment to ameliorate de
Externí odkaz:
https://doaj.org/article/bdde62f208b945bebe1e3ec880cbbf07
Autor:
Peter V. Dicpinigaitis
Publikováno v:
ERJ Open Research, Vol 7, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/e09a52a1ce354b6998adf85abf4a4857
Autor:
David R. Muccino, Alyn H. Morice, Surinder S. Birring, Peter V. Dicpinigaitis, Ian D. Pavord, Christopher Assaid, Huub Jan Kleijn, Azher Hussain, Carmen La Rosa, Lorcan McGarvey, Jaclyn A. Smith
Publikováno v:
ERJ Open Research, Vol 6, Iss 4 (2020)
Background We present study designs, dose selection and preliminary patient characteristics from two phase 3 clinical trials of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough (RCC) or unexplained chronic cough (UCC). Methods COUG
Externí odkaz:
https://doaj.org/article/797aecd766a64455a4cd9c812cd2c339
Autor:
Lorcan McGarvey, Jaclyn A. Smith, Alyn Morice, Surinder S. Birring, Kian Fan Chung, Peter V. Dicpinigaitis, Akio Niimi, Michael S. Benninger, Mandel Sher, Yuko Matsunaga, Sayaka Miyazaki, Mitsuaki Machida, Hiroyuki Ishihara, Adnan Mahmood, Juan-Carlos Gomez
Publikováno v:
McGarvey, L, Smith, J A, Morice, A, Birring, S S, Chung, K F, Dicpinigaitis, P V, Niimi, A, Benninger, M S, Sher, M, Matsunaga, Y, Miyazaki, S, Machida, M, Ishihara, H, Mahmood, A & Gomez, J-C 2022, ' A randomized, double-blind, placebo-controlled, parallel-group phase 2b trial of p2x3 receptor antagonist sivopixant for refractory or unexplained chronic cough ', Lung . https://doi.org/10.1007/s00408-022-00592-5
Introduction To determine the optimal dose of sivopixant, a highly selective P2X3 receptor antagonist, for refractory or unexplained chronic cough (RCC/UCC). Methods In this phase 2b, randomized, double-blind, placebo-controlled, parallel-group, mult
Publikováno v:
Multidisciplinary Respiratory Medicine, Vol 12, Iss 1, Pp 1-11 (2017)
Abstract Guaifenesin, a mucoactive drug, acts by loosening mucus in the airways and making coughs more productive. It is used for relief of wet cough and chest congestion due to the common cold, and remains the only legally marketed expectorant in th
Externí odkaz:
https://doaj.org/article/ff3c8b0550ee42d3a73c9bc56a031c71
Autor:
Surinder S Birring, Alyn H. Morice, Peter V Dicpinigaitis, Lorcan P. McGarvey, Ian D Pavord, Stuart A Green, George Philip, Jaclyn A Smith
Publikováno v:
American Journal of Respiratory and Critical Care Medicine.
Autor:
Surinder S Birring, Peter V Dicpinigaitis, Jaclyn A Smith, Alyn H. Morice, Lorcan P. McGarvey, Ian D Pavord, Allison Martin Nguyen, Jonathan Schelfhout, Qing Li, Beata Iskold, Stuart A Green, George Philip, David R. Muccino, Carmen La Rosa
Publikováno v:
American Journal of Respiratory and Critical Care Medicine.